Benefits Think Healthcare is a problem. This employer has a solution
Asking difficult questions, pushing for transparency, and challenging how prices are set have helped a healthcare provider offer better coverage to its employees.
Healthcare costs
Forging stronger broker-TPA partnerships
Collaboration between employers, brokers and third-party administrators will be essential to developing customized, cost-effective and employee-friendly solutions.
Web Seminar Affordability is a long game. Payability delivers today.
Healthcare affordability has been the organizing principle of benefits strategy for decades — and that work matters. But there's a gap no negotiated rate can close: 38% of insured employees delayed or skipped care last year because they couldn't pay when it was needed. Not because they lacked coverage. Because they couldn't pay.
Case Study How employers can improve retention and lower healthcare costs
See how one employer took a more connected approach to supporting employees and improved retention, pregnancy outcomes, and healthcare costs along the way.
Web Seminar The cancer attention gap: Why employers are underinvesting in their biggest cost risk
Whether you're shaping benefits, guiding clinical strategy, or advising employers, this session will give you the data and the framework to put cancer back on the executive radar.
Web Seminar Beyond the renewal: What over 1,500 SMBs are doing about soaring healthcare costs
Healthcare costs are squeezing employer margins, and small and midsize employers aren't waiting for another renewal to act. They're rethinking how they fund healthcare, manage costs, and partner with advisors.
By
lyle
How sticking with ICHRAs minimizes disruption, part 2
With this alternative model, benefit professionals have the potential to not only stabilize employee health benefit costs but actually return dividends.
How sticking with ICHRAs minimizes disruption, part 1
Experts suggest locking in this emerging alternative to traditional health insurance coverage to help stabilize soaring health benefit costs.
How to make cell and gene therapies affordable
Brokers are urged to read the fine print on stop-loss contracts to ensure adequate coverage is in place, and have clients pool risk whenever necessary.
Guide Why employers overpay for specialty infusions—and how to take back control
A guide for benefits leaders at self-funded employers on controlling specialty infusion spend without disrupting care.
What 2026 open enrollment reveals about cost pressures ahead
Advisers say the health insurance market could stay hardened in 2027 and beyond amid greater involvement in benefit design strategies from executive teams.
GLP-1s and ICHRAs took center stage in latest OE
Employers are feeling pressured to cover weight-loss drugs without breaking the bank, and considering an alternative to traditional health insurance.
OE look-back: Advisers reach a cost tipping point in 2026
Benefit advisers unpack their latest client experiences helping employers respond to a hardening group health insurance market and employee education challenges.
Congress’ push to rein in drug costs will impact benefit strategies
New drug pricing proposals could reshape employer pharmacy strategy, as benefit managers struggle to navigate rising prescription costs.
Cash-pay option expands care access
Sidecar Health's approach removes barriers associated with provider network restrictions, prior authorization, formularies and step care.
Double-digit healthcare costs are here: 5 strategies for benefit managers to regain control
As health plan costs continue to climb, "doing nothing" has become the most expensive strategy of all, says this panel of benefit experts.
White Paper Building better benefits: The employer’s blueprint for modern health plans
A one-size-fits all health insurance approach often fails to meet the needs of a modern and diverse workforce. This white paper outlines how ICHRAs foster budget sustainability and employee choice.
EBN’s Best of 2025: Leaders confront climbing healthcare costs
Benefit leaders found innovative and cost-effective ways to deal with increasing strain on their healthcare budgets.
Expanding HSA eligibility could pay for GLP-1s
With about 7 million additional Americans expected to sign up for HSAs, these vehicles can help finance costly GLP-1s.
White paper Transparency and innovative cost-containment strategies are the keys to reducing pharmaceutical costs
HR and benefits leaders have a significant opportunity to expand their playbooks with proven methods to overcome their most intractable challenge.
